Israeli firm to provide filtration for Ashdod plant

Amiad Water Systems signs NIS 6m. deal to provide purification mechanisms for the future desalination plant in Ashdod.

July 2, 2012 23:16
2 minute read.
Desalination plant in Hadera

Desalination plant in Hadera 311 (R). (photo credit: REUTERS / Nir Elias)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Israeli water-filtration firm Amiad Water Systems has signed an agreement for at least NIS 6 million to provide purification mechanisms for the future desalination plant in Ashdod.

The agreement represents the first time an Israeli firm will supply filtration systems to a desalination plant in Israel on a significant scale, the company said. Amiad signed the agreement with the IVM consortium, a group that includes Israeli company Minrav Holding Ltd. and SADYT of Spain, which won the international tender to build the desalination plant from Mekorot, the national water company.

Be the first to know - Join our Facebook page.

Both the filtration system and the desalination facility, which is expected to provide 100 million cubic meters of water annually, are slated to be in use by 2013.

“I am happy about the agreement signed with IVM for the new Mekorot desalination plant, which will enable an Israeli filtration system – produced ‘blue and white’ – to be installed on one of the biggest desalination plants in Israel for the first time on a significant scale,” Amiad CEO Arik Dayan said.

The purification mechanisms will use Amiad’s Arkal automatic cleaning-disk technology, which provides protection to both the ultrafiltration and reverse-osmosis membranes of the desalination facilities, the company said. Such membranes are some of the most sensitive and difficult to clean elements of desalination plants, Amiad said.

The polymer materials that compose the filtration systems are highly resistant to damage from seawater, and they provide an alternative solution to cleansing mechanisms that involve chemicals and electricity, Dayan said.

There are large-scale desalination facilities in Palmahim, Hadera and Ashkelon, while plants at Ashdod and Soreq are under development. The three existing facilities currently produce about 300 annually. But with the addition of Ashdod and Soreq, as well as the doubling of Palmahim in size, the government has expressed hopes that desalinated water will cover 85 percent of domestic water consumption by 2013. In January, the process to double the size of the Palmahim facility from 45 to 90 began.

“The desalination facility in Ashdod is another step in a long string of achievements in the field of water supply, quality and maximum reliability at all times and under all circumstances,” Mekorot CEO Shimon Ben-Hamo said. “The integration of the filtration systems at the facility match the company’s policies in technological development.”

This winter, Amiad signed two projects similar to that of Ashdod in Australia, worth about $8m. and $1.6m., the company said.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection